Translate
Sunshine Biopharma Inc
About
Sunshine Biopharma Inc (NASDAQ:SBFM) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 6 2026
Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year
Oct 28 2025
Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)
Oct 28 2025
Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea
Oct 20 2025
Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline
Oct 16 2025
Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin
Financials
Revenue
$37.32 M
Market Cap
$5.1 M
P/E Ratio
0.20
EPS
5.31